Search Page
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 1927 | 1 |
| 1928 | 1 |
| 1933 | 1 |
| 1934 | 1 |
| 1937 | 2 |
| 1938 | 2 |
| 1939 | 1 |
| 1945 | 1 |
| 1946 | 2 |
| 1947 | 3 |
| 1948 | 5 |
| 1949 | 6 |
| 1950 | 7 |
| 1951 | 6 |
| 1952 | 11 |
| 1953 | 12 |
| 1954 | 7 |
| 1955 | 1 |
| 1956 | 10 |
| 1957 | 12 |
| 1958 | 11 |
| 1959 | 7 |
| 1960 | 14 |
| 1961 | 13 |
| 1962 | 17 |
| 1963 | 16 |
| 1964 | 10 |
| 1965 | 8 |
| 1966 | 16 |
| 1967 | 14 |
| 1968 | 5 |
| 1969 | 13 |
| 1970 | 85 |
| 1971 | 408 |
| 1972 | 576 |
| 1973 | 792 |
| 1974 | 876 |
| 1975 | 983 |
| 1976 | 1054 |
| 1977 | 1094 |
| 1978 | 1352 |
| 1979 | 1053 |
| 1980 | 724 |
| 1981 | 575 |
| 1982 | 590 |
| 1983 | 725 |
| 1984 | 759 |
| 1985 | 774 |
| 1986 | 878 |
| 1987 | 1045 |
| 1988 | 1256 |
| 1989 | 1566 |
| 1990 | 1876 |
| 1991 | 2020 |
| 1992 | 2171 |
| 1993 | 2563 |
| 1994 | 2870 |
| 1995 | 3996 |
| 1996 | 4859 |
| 1997 | 5584 |
| 1998 | 6199 |
| 1999 | 6928 |
| 2000 | 7593 |
| 2001 | 8109 |
| 2002 | 8994 |
| 2003 | 10368 |
| 2004 | 11339 |
| 2005 | 13006 |
| 2006 | 14436 |
| 2007 | 15723 |
| 2008 | 17106 |
| 2009 | 18604 |
| 2010 | 20814 |
| 2011 | 22873 |
| 2012 | 25076 |
| 2013 | 27328 |
| 2014 | 29712 |
| 2015 | 31630 |
| 2016 | 33127 |
| 2017 | 35478 |
| 2018 | 37285 |
| 2019 | 40523 |
| 2020 | 46911 |
| 2021 | 50783 |
| 2022 | 47979 |
| 2023 | 47609 |
| 2024 | 55992 |
| 2025 | 16536 |
Search Results
671,382 results
Results by year
Citations
1
article
found by citation matching
Search results
Page 1
Mechanisms of NAFLD development and therapeutic strategies.
Nat Med. 2018 Jul;24(7):908-922. doi: 10.1038/s41591-018-0104-9. Epub 2018 Jul 2.
Nat Med. 2018.
PMID: 29967350
Free PMC article.
Review.
Here we review the pathogenic and clinical features of NAFLD, its major comorbidities, clinical progression and risk of complications and in vitro and animal models of NAFLD enabling refinement of therapeutic targets that can accelerate drug development. We a …
Here we review the pathogenic and clinical features of NAFLD, its major comorbidities, clinical progression and risk of …
The Alzheimer's Disease Clinical Spectrum: Diagnosis and Management.
Med Clin North Am. 2019 Mar;103(2):263-293. doi: 10.1016/j.mcna.2018.10.009.
Med Clin North Am. 2019.
PMID: 30704681
Free article.
Review.
Clinical biomarkers are available to aid high confidence in etiologic diagnosis. Management uses psychoeducation, shared goal setting, and patient-caregiver dyad decision making. When combined, pharmacologic and nonpharmacologic therapies mitigate symptoms and reduce cl …
Clinical biomarkers are available to aid high confidence in etiologic diagnosis. Management uses psychoeducation, shared goal setting …
Reply.
Clin Gastroenterol Hepatol. 2020 Feb;18(2):523-524. doi: 10.1016/j.cgh.2019.07.041. Epub 2019 Jul 25.
Clin Gastroenterol Hepatol. 2020.
PMID: 31352095
No abstract available.
Prediction of clinical progression in nervous system diseases: plasma glial fibrillary acidic protein (GFAP).
Eur J Med Res. 2024 Jan 12;29(1):51. doi: 10.1186/s40001-023-01631-4.
Eur J Med Res. 2024.
PMID: 38216970
Free PMC article.
Review.
For example, previous published literatures showed that autoimmune GFAP astrocytopathy is an inflammatory disease of the central nervous system (CNS). Moreover, the studies of GFAP in brain tumors mainly focus on the predictive value of tumor volume. ...This review …
For example, previous published literatures showed that autoimmune GFAP astrocytopathy is an inflammatory disease of the central nerv …
HIV, Subclinical Cardiovascular Disease, and Clinical Progression: Insights From Immunologic Heterogeneity.
JAMA. 2022 Sep 13;328(10):931-932. doi: 10.1001/jama.2022.15226.
JAMA. 2022.
PMID: 36098735
Free PMC article.
No abstract available.
Bevacizumab for the early clinical progression of diffuse intrinsic pontine glioma.
Pediatr Int. 2023 Jan-Dec;65(1):e15575. doi: 10.1111/ped.15575.
Pediatr Int. 2023.
PMID: 37551654
No abstract available.
Capivasertib delays disease progression.
Nat Rev Clin Oncol. 2023 Sep;20(9):579. doi: 10.1038/s41571-023-00790-x.
Nat Rev Clin Oncol. 2023.
PMID: 37311901
No abstract available.
Predictors of progression from subjective cognitive decline to objective cognitive impairment: A systematic review and meta-analysis of longitudinal studies.
Int J Nurs Stud. 2024 Jan;149:104629. doi: 10.1016/j.ijnurstu.2023.104629. Epub 2023 Oct 28.
Int J Nurs Stud. 2024.
PMID: 37979370
Review.
With increasing awareness of brain health and a rising prevalence of dementia, a growing number of individuals seek medical assistance for purely subjective cognitive decline. However, only individuals with specific characteristics tend to experience clinical pro …
With increasing awareness of brain health and a rising prevalence of dementia, a growing number of individuals seek medical assistance for p …
Acquired Anophthalmic Socket: Clinical Course and Treatment Options.
Int Ophthalmol Clin. 2023 Jul 1;63(3):163-185. doi: 10.1097/IIO.0000000000000459. Epub 2023 Jun 22.
Int Ophthalmol Clin. 2023.
PMID: 37439616
No abstract available.
Letter to the editor: Relevance of population-based cutoffs to define frailty in clinical studies.
Hepatology. 2022 Apr;75(4):1067-1068. doi: 10.1002/hep.32321. Epub 2022 Feb 3.
Hepatology. 2022.
PMID: 35006628
No abstract available.
Cite